5 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 4 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Not yet recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Lumen Bioscience, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Intranasal LMN-1001 in Healthy Adults LMN-1001 - Viral Infections | Phase 1 | Not yet recruiting | Lumen Bioscience, Inc. | 36 | 2026-11-09 | 2026-10-01 |
| G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies LMN-401 - Travelers Diarrhea | Early Phase 1 | Recruiting | Lumen Bioscience, Inc. | 12 | 2024-12-04 | 2025-01-09 |
| LMN-201 for Prevention of C. Difficile Infection Recurrence LMN-201, Placebo - Clostridioides Difficile Infection | Phase 2 / Phase 3 | Active not recruiting | Lumen Bioscience, Inc. | 375 | 2024-08-29 | 2026-10-05 |
| Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia TAQMan Array Card - Travelers Diarrhea | Completed | Lumen Bioscience, Inc. | 2400 | 2024-06-20 | 2026-07-15 | |
| A Study to Determine the Tolerability of Intranasal LMN-301 LMN-301 - COVID-19 | Phase 1 | Completed | Lumen Bioscience, Inc. | 35 | 2023-10-06 | 2025-07-30 |
| LMN-101 in a Campylobacter Human Challenge Model LMN-101, Placebo - Campylobacter Infections | Phase 2 | Completed | Lumen Bioscience, Inc. | 42 | 2022-02-21 | 2025-09-25 |
| Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies LMN-201 Anti-toxin B VHH-1, LMN-201 Anti-toxin B VHH-2, LMN-201 Anti-toxin B VHH-3 - C. Diff. Infections | Phase 1 | Completed | Lumen Bioscience, Inc. | 12 | 2021-08-18 | 2025-03-18 |
| Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers LMN-101 - Campylobacter Jejuni Infection | Phase 1 | Completed | Lumen Bioscience, Inc. | 21 | 2019-11-15 | 2025-02-04 |
Clostridium Infections (2) · COVID-19 (1) · Campylobacter Infections (1) · Virus Diseases (1)
Starch (1)
Australia (6) · United States (2)
Carl Mason (1) · Mohamed Al-Ibrahim, MB,ChB, FACP (1) · Paul Griffin, MBBS (1)